Can I appeal an EPO opposition decision?

Can I appeal an EPO opposition decison?
Can I appeal an EPO opposition decison?
ARTICLE SUMMARY

A decision of the EPO Opposition Division can be appealed by any party adversely affected, such as the patent proprietor, an opponent, or a valid intervenor. The appellant must file a notice of appeal and pay the fee within two months, submit the grounds within four months, after which the Board of Appeal conducts an independent review that may uphold, overturn, or remit the case.

authors
Authors
Related Services
Related Industries

A decision of the EPO Opposition Division (OD) can be appealed, but only by a party who took part in the opposition proceedings and is adversely affected by the decision.

Under Article 107 EPC, an appeal is restricted to “any party to proceedings adversely affected by a decision,” which means the patent proprietor, an opponent, or a valid intervenor (e.g., an assumed infringer who intervened under Article 105 EPC).  

To validly appeal, the adversely affected party must file a notice of appeal and pay the appeal fee within two months of notification of the written decision and must submit the statement of grounds of appeal within four months. The Board of Appeal will then conduct an independent judicial review of the OD’s decision, which may result in the decision being upheld, set aside, or the case being remitted back to the OD for further examination.

Related News

Can I appeal an EPO opposition decision?

Can I appeal an EPO opposition decision?

EPO opposition vs appeal

EPO opposition vs appeal

From sketch to store, don't let anyone cut from your cloth

From sketch to store, don't let anyone cut from your cloth

The EUIPO SME fund: a guide for SMEs

The EUIPO SME fund: a guide for SMEs

13th edition of the Nice Classification now in force

13th edition of the Nice Classification now in force

EU trilogue opens regulatory pathway for plants developed using new genomic techniques (NGTs) to the benefit of agritech and foodtech innovators

EU trilogue opens regulatory pathway for plants developed using new genomic techniques (NGTs) to the benefit of agritech and foodtech innovators

Sportstech and the IP frontier: how do you protect sportstech innovation in the digital age?

Sportstech and the IP frontier: how do you protect sportstech innovation in the digital age?

The European Parliament and Council reach provisional agreement on the EU “pharma package”

The European Parliament and Council reach provisional agreement on the EU “pharma package”

See All News
No items found.